Regulations.gov document
Response from Boehringer Ingelheim Pharmaceuticals (Covington) to FDA CDER
Other · FDA-2006-O-0057 · posted Jan 28, 2016
Key facts
| Document ID | FDA-2006-O-0057-0055 |
|---|---|
| Title | Response from Boehringer Ingelheim Pharmaceuticals (Covington) to FDA CDER |
| Document type | Other |
| Subtype | Response(s) |
| Agency | FDA |
| Docket | FDA-2006-O-0057 |
| Posted | Jan 28, 2016 |
| Comment period opens | Jan 28, 2016 |
At a glance
- 1–9 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: